Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice

Physiology and Behavior

Volumn 95, Issue 1-2, 2008, Pages 267-270

  Farook, Justin M ^a   Krazem, Ali ^a   Lewis, Ben ^a   Morrell, Dennis J ^a   Littleton, John M ^a   Barron, Susan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Acamprosate; Alcohol; Convulsion; Mice; Swiss Webster; Withdrawal

Indexed keywords

4 METHYLPYRAZOLE; ACAMPROSATE; ALCOHOL; DIAZEPAM;

ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SWISS WEBSTER MOUSE;

EID: 49349093990     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.05.020     Document Type: Article

References (40)

1. Friedman H.J. Assessment of physical dependence on and withdrawal from ethanol in animals. In: Rigter H., and Crabbe J.C. (Eds). Alcohol tolerance and dependence (1980), Elsevier/North-Holland Biomedical Press, Amsterdam 93-121
2. Metten P., and Crabbe J.C. Alcohol withdrawal severity in inbred mouse (Mus musculus) strains. Behav Neurosci 119 (2005) 911-925
3. Veatch L.M., and Becker H.C. Electrographic and behavioral indices of ethanol withdrawal sensitization. Brain Res 946 (2002) 272-282
4. Goldstein D.B., and Pal N. Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 172 (1971) 288-290
5. Crabbe J.C., Janowsky J.S., Young E.R., and Rigter H. Handling induced convulsions in twenty inbred strains of mice. Subst Alcohol Actions/Misuse 1 (1980) 159-163
6. Crabbe J.C., Merrill C.D., and Belknap J.K. Effects of convulsants on handling-induced convulsions in mice selected for ethanol withdrawal severity. Brain Res 550 (1991) 1-6
7. Belknap J.K., Laursen S.E., and Crabbe J.C. Ethanol and nitrous oxide produce withdrawal-induced convulsions by similar mechanisms in mice. Life Sci 41 (1987) 2033-2040
8. Grant K.A., Valverius P., Hudspith M., and Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 176 (1990) 289-296
9. Páez A.M., Shannon M., Maher T., and Quang L. Effects of 4-methylpyrazole on ethanol neurobehavioral toxicity in CD-1 mice. Acad Emerg Med 8 (2004) 820-826
10. Mayo-Smith M.F. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278 (1997) 144-151
11. Holbrook A.M., Crowther R., Lotter A., Cheng C., and King D. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 160 (1999) 649-655
12. Rowlett J.K., Platt D.M., Lelas S., Atack J.R., and Dawson G.R. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci 102 (2005) 915-920
13. Farook J.M., Morrell D.J., Lewis B., Littleton J.M., and Barron S. Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss Webster mice. Alcohol Alcohol 42 (2007) 296-300
14. Johnson B.A., and Ait-Daoud N. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology (Berl) 149 (2000) 327-344
15. Mason B.J. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review. J Clin Psychiatry 62 Suppl 20 (2001) 42-48
16. Dahchour A., and De Witte P. Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60 (2000) 343-362
17. Spanagel R., and Zieglgänsberger W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18 (1997) 54-59
18. Cole J.C., Littleton J.M., and Little H.J. Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze. Psychopharmacology (Berl) 147 (2000) 403-411
19. McGeehan A.J., and Olive M.F. The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. Br J Pharmacol 138 (2003) 9-12
20. Dahchour A., De Witte P., Bolo N., Nédélec J.F., Durbin P., and Macher J.P. Central effect of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate during ethanol withdrawn rats. Psychiatry Res Neuroimaging 82 (1998) 107-114
21. Mayer S., Harris B., Gibson D.A., Blanchard J., Prendergast M.A., Holley R.C., et al. Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat. Alcohol Clin Exp Res 26 (2002) 655-662
22. Quertemont E., Brabant C., and De Witte P. Acamprosate reduces context-dependent ethanol effects. Psychopharmacology 164 (2002) 10-18
23. Heyser C.J., Schulteis G., Durbin P., and Koob G.F. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18 (1998) 125-133
24. Wilson J., and Little H.J. CCK(B) antagonists protect against some aspects of the ethanol withdrawal syndrome. Pharmacol Biochem Behav 59 (1998) 967-973
25. Blomstrand R., Ostling-Wintzell H., Lof A., McMartin K., Tolf B.R., and Hedstrom K.G. Pyrazoles as inhibitors of alcohol oxidation and as important tools in alcohol research: an approach to therapy against methanol poisoning. Proc Natl Acad Sci 76 (1979) 3499-3503
26. Finn D.A., and Crabbe J.C. Chronic ethanol differentially alters susceptibility to chemically induced convulsions in withdrawal seizure-prone and -resistant mice. J Pharmacol Exp Ther 288 (1999) 782-790
27. De Witte P., Littleton J., Parot P., and Koob G. Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 19 (2005) 517-537
28. Hoffman P.L., and Tabakoff B. The role of the NMDA receptor in ethanol withdrawal. EXS 71 (1994) 61-70
29. Davidson M.D., Wilce P., and Stanley B.C. Increased sensitivity of the hippocampus in ethanol dependent rats to toxic effect of N-methyl-d-aspartic acid in vivo. Brain Res 606 (1993) 5-9
30. Kalluri H.S., Mehta A.K., and Ticku M.K. Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Brain Res Mol Brain Res 58 (1998) 221-224
31. Hoffman P.L. Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metab Brain Dis. 10 (1995) 73-79
32. Zeise M.L., Kasparov S., Capogna M., and Zieglgansberger W. Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Eur J Pharmacol 231 (1993) 47-52
33. Madamba S.G., Schweitzer P., Zieglgansberger W., and Siggins G.R. Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-d-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcohol Clin Exp Res 20 (1996) 651-658
34. Popp R.L., and Lovinger D.M. Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons. Eur J Pharmacol 394 (2000) 221-231
35. Littleton J.M., Lovinger D., Liljequist S., Ticku R., Matsumoto I., and Barron S. Role of polyamines and NMDA receptors in ethanol dependence and withdrawal. Alcohol Clin Exp Res 25 ISBRA Suppl 5 (2001) 132s-136s
36. Vengeliene V., Bachteler D., Danysz W., and Spanagel R. The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect. Neuropharmacology 48 (2005) 822-829
37. Bossert J.M., Liu S.Y., Lu L., and Shaham Y. A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 24 (2004) 10726-10730
38. Herzig V., and Schmidt W.J. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine. Neuropharmacology 47 (2004) 973-984
39. Cornish J.L., and Kalivas P.W. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20 (2000) RC89
40. Backstrom P., Bachteler D., Koch S., Hyytia P., and Spanagel R. mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropharmacology 29 (2004) 921-928